Sjögren M, Davidsson P, Tullberg M, Minthon L, Wallin A, Wikkelso C, Granérus AK, Vanderstichele H, Vanmechelen E, Blennow K. Both total and phosphorylated tau are increased in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2001 May;70(5):624-30. PubMed.
AlzBiomarker Database
Meta-Analysis
- AD vs CTRL : albumin ratio (CSF)
- CTRL vs AD : albumin ratio (CSF)
- FTD vs AD : albumin ratio (CSF)
- PD vs AD : albumin ratio (CSF)
- VaD vs AD : albumin ratio (CSF)
- AD vs CTRL : tau-p181 (CSF)
- CTRL vs AD : tau-p181 (CSF)
- FTD vs AD : tau-p181 (CSF)
- PD vs AD : tau-p181 (CSF)
- VaD vs AD : tau-p181 (CSF)
- AD vs CTRL : tau-total (CSF)
- CTRL vs AD : tau-total (CSF)
- FTD vs AD : tau-total (CSF)
- PD vs AD : tau-total (CSF)
- VaD vs AD : tau-total (CSF)
Curated Study Data
Biomarker (Source) |
Cohort (N) |
Measurement Mean ± SD |
Method; Assay Name; Manufacturer |
Diagnostic Criteria |
---|---|---|---|---|
albumin ratio (CSF/Blood) |
AD- Possible Alzheimer's Disease (19) |
7.9 ± 2.9 mg/L:g/L |
Nephelometry; Other/Not Specified; Other/Not Specified |
McKhann et al., 1984 |
albumin ratio (CSF/Blood) |
AD- Probable Alzheimer's Disease (41) |
5.4 ± 1.8 mg/L:g/L |
Nephelometry; Other/Not Specified; Other/Not Specified |
McKhann et al., 1984 |
albumin ratio (CSF/Blood) |
CTRL- CNC (17) |
5.3 ± 1.8 mg/L:g/L |
Nephelometry; Other/Not Specified; Other/Not Specified |
|
albumin ratio (CSF/Blood) |
CTRL- CNC (17) |
5.3 ± 1.8 mg/L:g/L |
Nephelometry; Other/Not Specified; Other/Not Specified |
|
albumin ratio (CSF/Blood) |
FTD (18) |
9.7 ± 2.9 mg/L:g/L |
Nephelometry; Other/Not Specified; Other/Not Specified |
1994 |
albumin ratio (CSF/Blood) |
PD (15) |
6.8 ± 2.4 mg/L:g/L |
Nephelometry; Other/Not Specified; Other/Not Specified |
Wallin et al., 1999 |
albumin ratio (CSF/Blood) |
VaD (17) |
11.9 ± 7.2 mg/L:g/L |
Nephelometry; Other/Not Specified; Other/Not Specified |
|
tau-p181 (CSF) |
AD- Possible Alzheimer's Disease (19) |
18.01 ± 5.86 pM |
ELISA; Innotest; Innogenetics |
McKhann et al., 1984 |
tau-p181 (CSF) |
AD- Probable Alzheimer's Disease (41) |
23.1 ± 10.1 pM |
ELISA; Innotest; Innogenetics |
McKhann et al., 1984 |
tau-p181 (CSF) |
CTRL- CNC (17) |
15.9 ± 5.7 pM |
ELISA; Innotest; Innogenetics |
|
tau-p181 (CSF) |
CTRL- CNC (17) |
15.9 ± 5.7 pM |
ELISA; Innotest; Innogenetics |
|
tau-p181 (CSF) |
FTD (18) |
8.6 ± 3.9 pM |
ELISA; Innotest; Innogenetics |
1994 |
tau-p181 (CSF) |
PD (15) |
14.1 ± 3.1 pM |
ELISA; Innotest; Innogenetics |
Wallin et al., 1999 |
tau-p181 (CSF) |
VaD (17) |
6.4 ± 5.6 pM |
ELISA; Innotest; Innogenetics |
|
tau-total (CSF) |
AD- Possible Alzheimer's Disease (19) |
16.34 ± 4.3 pM |
ELISA; Innotest; Innogenetics |
McKhann et al., 1984 |
tau-total (CSF) |
AD- Probable Alzheimer's Disease (41) |
20 ± 7.6 pM |
ELISA; Innotest; Innogenetics |
McKhann et al., 1984 |
tau-total (CSF) |
CTRL- CNC (17) |
8.3 ± 2.8 pM |
ELISA; Innotest; Innogenetics |
|
tau-total (CSF) |
CTRL- CNC (17) |
8.3 ± 2.8 pM |
ELISA; Innotest; Innogenetics |
|
tau-total (CSF) |
FTD (18) |
9.7 ± 2.9 pM |
ELISA; Innotest; Innogenetics |
1994 |
tau-total (CSF) |
PD (15) |
7.5 ± 1.6 pM |
ELISA; Innotest; Innogenetics |
Wallin et al., 1999 |
tau-total (CSF) |
VaD (17) |
3.7 ± 2.3 pM |
ELISA; Innotest; Innogenetics |
Recommends
Please login to recommend the paper.
This paper appears in the following:
News
AlzBiomarker
- AD vs CTRL : albumin ratio (CSF)
- CTRL vs AD : albumin ratio (CSF)
- FTD vs AD : albumin ratio (CSF)
- PD vs AD : albumin ratio (CSF)
- VaD vs AD : albumin ratio (CSF)
- AD vs CTRL : tau-p181 (CSF)
- CTRL vs AD : tau-p181 (CSF)
- FTD vs AD : tau-p181 (CSF)
- PD vs AD : tau-p181 (CSF)
- VaD vs AD : tau-p181 (CSF)
- AD vs CTRL : tau-total (CSF)
- CTRL vs AD : tau-total (CSF)
- FTD vs AD : tau-total (CSF)
- PD vs AD : tau-total (CSF)
- VaD vs AD : tau-total (CSF)
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.